We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

106 hedge funds and large institutions have $185M invested in Surgalign Holdings, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

6% less funds holding

Funds holding: 113106 (-7)

28% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 18

30% less capital invested

Capital invested by funds: $264M → $185M (-$78.7M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
106
Holders Change
-7
Holders Change %
-6.19%
% of All Funds
2.3%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
13
Increased
38
Reduced
32
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
1
Paradigm Capital Management Inc
New York
$25.5M +$359K +2,493 +1%
BlackRock
2
BlackRock
New York
$22.8M +$1.31M +9,062 +5%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$21M +$615K +4,270 +3%
KAM
4
Krensavage Asset Management
New York
$16.6M -$261K -1,809 -1%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$12.4M +$7.68M +53,340 +122%
Vanguard Group
6
Vanguard Group
Pennsylvania
$11.9M +$287K +1,994 +2%
RSCM
7
Rock Springs Capital Management
Maryland
$8.29M
Renaissance Technologies
8
Renaissance Technologies
New York
$6.07M -$39.3K -273 -0.6%
HC
9
Hillman Company
Pennsylvania
$4.59M
State Street
10
State Street
Massachusetts
$4.58M +$8.35K +58 +0.2%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$4.44M +$140K +975 +3%
RCM
12
Rutabaga Capital Management
Massachusetts
$3.53M -$392K -2,720 -9%
RA
13
Royce & Associates
New York
$3.42M +$165K +1,148 +4%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.34M +$241K +1,676 +7%
KIA
15
Kopp Investment Advisors
Minnesota
$3.07M -$793K -5,510 -19%
Northern Trust
16
Northern Trust
Illinois
$3.06M +$99.7K +692 +3%
Victory Capital Management
17
Victory Capital Management
Texas
$2M +$244K +1,697 +12%
FP
18
Foundry Partners
Minnesota
$1.96M -$395K -2,742 -15%
WCM
19
Wedge Capital Management
North Carolina
$1.36M -$306K -2,122 -17%
BCM
20
Bridgeway Capital Management
Texas
$1.29M -$1.19M -8,290 -45%
MAG
21
Millrace Asset Group
Pennsylvania
$1.22M -$347K -2,409 -20%
N
22
Nuveen
North Carolina
$1.22M +$1.38M +9,553 New
CLG
23
Cooperman Leon G
$1.04M +$228K +1,584 +24%
SBH
24
Segall Bryant & Hamill
Illinois
$944K +$242K +1,677 +29%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$902K -$112K -777 -10%

SRGA Hedge Fund Activity: Q2 2019 in Review

106 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2019, worth a combined $185M — down 30% from $264M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of SRGA and 13 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 38 added.

The largest buyer was Wellington Management Group, adding an estimated $7.68M. The largest seller was Russell Investments Group, cutting an estimated $2.83M.

  • 106 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2019, down from 113 in Q1 2019.
  • Funds reported $185M of Surgalign Holdings, Inc. Common Stock stock for Q2 2019, down 30% quarter-over-quarter.
  • 13 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2019 and 18 closed out, a net change of -5 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2019 was Wellington Management Group, an estimated $7.68M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2019 was Russell Investments Group, an estimated $2.83M sold.

Based on aggregated 13F filings for Q2 2019.